Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Reporting from the frontiers of health and medicine

In the Lab

With the Nobel Prizes around the corner, it’s crystal ball time

By Sharon Begley

First Opinion

Why did it take the CDC so long to reverse course on debunked treatments for chronic fatigue syndrome?

By Julie Rehmeyer and David Tuller

Pharmalot

What’s on pharma’s wish list? Tell us what you think

By Ed Silverman

Business Pfizer spends billions to develop new drugs. It’s not satisfied. So it’s launching a startup
In the Lab To advance medicine’s future, the NIH tries to win the trust of communities mistreated in the past
First Opinion Military medics and corpsmen could help fill the shortage of primary care providers
Hospitals Another health care deadline looms: Payments to safety net hospitals due to expire next week
Business CVS tightens restrictions on opioid prescriptions in bid to stanch epidemic

House committee looking for answers from Merck on its June cyberattack
Zapping the brain for stroke rehab: Pivotal clinical trial begins
Just months after expanding, biotech incubator LabCentral growing again

advertisement

Follow Us

Special Report

As a scientist, he studied trauma victims. Then he became one

By Andrew Joseph

First Opinion

I told my emergency medicine team to ‘move on’ after a horrific patient death. That was a mistake

By Jay Baruch

Heavyweights

Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee

By Meghana Keshavan

Hospitals

A $200 million gift promotes alternative therapies at a California medical school — and critics recoil

By Usha Lee McFarling

A STAT Investigation

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close

By Casey Ross and Ike Swetlitz

Health

White nationalists are flocking to genetic ancestry tests. Some don’t like what they find

By Eric Boodman

First Opinion Why did it take the CDC so long to reverse course on debunked treatments for chronic fatigue syndrome?
In the Lab With the Nobel Prizes around the corner, it’s crystal ball time
A STAT Investigation IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close
Business Pfizer spends billions to develop new drugs. It’s not satisfied. So it’s launching a startup
Biotech The Biotech Devil’s Dictionary: Your guide to the inanities of industry jargon

All Popular Stories

By Megan Thielking

Get ahead of the day's health and medicine news with our Morning Rounds newsletter.

Please enter a valid email address.

Video

VIDEO: This is why science loves twins

By Jeffery DelViscio and Thomas DelViscio

In the Lab

WATCH: A race to the US to save a newborn’s eyesight

By Fan Bu and Melody Cao

In the Lab

Inside a DEA drug lab, a race to identify dangerous new opioids

Health

Climate change: It’s the mother of all human health issues

By Jeffery DelViscio and Dominic Smith

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

Industry

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT

X